Treating HIV during pregnancy: an update on safety issues.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMID 16752931)

Published in Drug Saf on January 01, 2006

Authors

D Heather Watts1

Author Affiliations

1: Pediatric, Adolescent, and Maternal AIDS Branch, Center for Research for Mothers and Children, National Institute of Child Health and Human Development, Rockville, Maryland, USA. wattsh@mail.nih.gov

Articles citing this

Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women. Br J Clin Pharmacol (2008) 1.04

Role of placental ATP-binding cassette (ABC) transporters in antiretroviral therapy during pregnancy. J Pharm Sci (2009) 0.95

Protective effect of pregnancy in rural South Africa: questioning the concept of "indirect cause" of maternal death. PLoS One (2013) 0.95

Effects of in utero antiretroviral exposure on mitochondrial DNA levels, mitochondrial function and oxidative stress. HIV Med (2011) 0.91

Zidovudine and Lamivudine for HIV Infection. Clin Med Rev Ther (2010) 0.89

In utero exposure of female CD-1 mice to AZT and/or 3TC: II. Persistence of functional alterations in cardiac tissue. Cardiovasc Toxicol (2010) 0.89

Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants. JAMA Pediatr (2015) 0.87

Pregnancy outcomes in women with advanced HIV infection in Italy. AIDS Patient Care STDS (2011) 0.86

In utero exposure of female CD-1 Mice to AZT and/or 3TC: I. Persistence of microscopic lesions in cardiac tissue. Cardiovasc Toxicol (2010) 0.86

Haematological safety of perinatal zidovudine in pregnant HIV-1-infected women in Thailand: secondary analysis of a randomized trial. PLoS Clin Trials (2007) 0.83

Mutational analysis of the mitochondrial tRNA genes and flanking regions in umbilical cord tissue from uninfected infants receiving AZT-based therapies for prophylaxis of HIV-1. Environ Mol Mutagen (2009) 0.81

Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design. AIDS (2016) 0.81

WR1065 mitigates AZT-ddI-induced mutagenesis and inhibits viral replication. Environ Mol Mutagen (2009) 0.81

Transplacental exposure to AZT induces adverse neurochemical and behavioral effects in a mouse model: protection by L-acetylcarnitine. PLoS One (2013) 0.80

Short communication: High prevalence of vitamin D deficiency in HIV-infected and HIV-uninfected pregnant women. AIDS Res Hum Retroviruses (2013) 0.76

Vitamin D Deficiency in HIV Infection: Not Only a Bone Disorder. Biomed Res Int (2015) 0.76